Shimadzu Scientific Instruments Names New President
Katsuaki Kaito has been named president of Shimadzu Scientific Instruments.
Shimadzu Corporation announced on July 21 that it has named Katsuaki Kaito president of Shimadzu Scientific Instruments (SSI). Kaito will be responsible for all sales and management functions for SSI, the American subsidiary of Shimadzu Corporation (Kyoto, Japan). He takes the place of former SSI president Shuzo Maruyama, who has been promoted to general manager of the analytical and measuring division.
Kaito joined the company’s liquid chromatography department 32 years ago and has spent 14 years performing R&D functions and 18 years in manufacturing. He was president of Shimadzu USA Manufacturing from 2003 to 2008; since then, he has served as general manager of the analytical and measuring instruments plant.
Kaito earned a degree in mechanical engineering from the University of Tokyo.
Source: Shimadzu Scientific Instruments
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.
